• Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157_Arg158insLeu (c.472_473ins3); Zygosity=Unspecified (from parent cell line).
  

PubMed=26735014; DOI=10.1038/nature16508; PMCID=PMC4854653
Shao-Kun Shu, Charles Y. Lin, Hou-Sheng Hansen He, Robert M. Witwicki, Doris Priscilla Tabassum, Justin M. Roberts, Michalina Janiszewska, Sung Jin Huh, Yi Liang, Jeremy Ryan, Ernest Doherty ...Show all 39 authors... , Hisham Mohammed, Hao Guo, Daniel G. Stover, Muhammad B. Ekram, Jonathan Brown, Clive D'Santos, Ian Elliott Krop, Deborah Dillon, Michael R. McKeown, Christopher Ott, Jun Qi, Min Ni, Prakash K. Rao, Melissa Duarte, Shwu-Yuan Wu, Cheng-Ming Chiang, Lars Anders, Richard Allen Young, Eric Winer, Anthony George Letai, William T. Barry, Jason S. Carroll, Henry Long, Myles A. Brown, Xiao-Le Shirley Liu, Clifford A. Meyer, James E. Bradner, Kornelia Polyak; Show fewer authors
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Nature 529:413-417(2016)

PubMed=32416067; DOI=10.1016/j.molcel.2020.04.027; PMCID=PMC7306005
Shao-Kun Shu, Hua-Jun Wu, Jennifer Y. Ge, Rhamy Zeid, Isaac S. Harris, Bojana Jovanovic, Katherine Murphy, Bin-Bin Wang, Xin-Tao Qiu, Jennifer E. Endress, Jaime Reyes ...Show all 39 authors... , Klothilda Lim, Alba Font-Tello, Sudeepa Syamala, Teng-Fei Xiao, Chandra Sekhar Reddy Chilamakuri, Evangelia K. Papachristou, Clive D'Santos, Jayati Anand, Kunihiko Hinohara, Wei Li, Thomas O. McDonald, Adrienne Luoma, Rebecca J. Modiste, Quang-De Nguyen, Brittany Michel, Paloma Cejas, Cigall Kadoch, Jacob D. Jaffe, Kai W. Wucherpfennig, Jun Qi, Xiao-Le Shirley Liu, Henry Long, Myles A. Brown, Jason S. Carroll, Joan Siefert Brugge, James E. Bradner, Franziska Michor, Kornelia Polyak; Show fewer authors
Synthetic lethal and resistance interactions with BET bromodomain inhibitors in triple-negative breast cancer.
Mol. Cell 78:1096-1113.e8(2020)